{"id": "1582325720172310530", "text": "$LLY to acquire $AKUS, a company developing AAV gene therapy for the treatment of inner ear conditions including sensorineural hearing loss, for $12.5/share in cash plus $3/share CVR for total up to $610m. https://t.co/zVPC6NF8ei", "edit_history_tweet_ids": ["1582325720172310530"], "author_id": "103011458", "created_at": "2022-10-18T11:00:24.000Z"}
{"created_at": "2022-10-18T20:10:58.000Z", "id": "1582464274118905856", "edit_history_tweet_ids": ["1582464274118905856"], "text": "We are glad to help this member reach his goal. Check out what he said in his updated review of our server \nhttps://t.co/nbm9ktQzvT\n\n$CMCSA $PEP $SAP $XOM $ABBV $ABT $TM $CRM $ORCL $CVX $ASML $LLY $TMO $AMGN $AZN $NKECHL $COST $MCD $ACN $BMY $DHR $NEE $SNY $CHTR $MDT $TMUS https://t.co/7Aldmvled8", "author_id": "1572609223065993217"}
{"created_at": "2022-10-18T19:25:44.000Z", "id": "1582452891864137728", "edit_history_tweet_ids": ["1582452891864137728"], "text": "$LLY Target Price, Sold limit, Take profits https://t.co/MAqeeefDh4 .", "author_id": "1578491761567363073"}
{"created_at": "2022-10-18T19:05:57.000Z", "id": "1582447911316910081", "edit_history_tweet_ids": ["1582447911316910081"], "text": "Trending: Pharmaceutical\n\n$JNJ -0.47 %\n$AZN -0.94 %\n$SLRX -45.20 %\n$MIST -8.87 %\n$ABBV -0.24 %\n$ATXI 5.90 %\n$TEVA 1.34 %\n$LLY -0.10 %\n$ABEO -8.17 %\n$JUPW 0.02 %\n\nhttps://t.co/WV3qS0lE4Q", "author_id": "1448619461892771843"}
{"created_at": "2022-10-18T19:46:54.000Z", "id": "1582458216025362435", "edit_history_tweet_ids": ["1582458216025362435"], "text": "Insider Lilly Endowment Inc reports selling 79,624 shares of $LLY for a total cost of $26,706,631.54 https://t.co/QivRmD7RUM", "author_id": "1477781646237585408"}
{"id": "1582366711801843712", "edit_history_tweet_ids": ["1582366711801843712"], "created_at": "2022-10-18T13:43:17.000Z", "text": "RT @JacobPlieth: $RHHBY: we do not yet have any (gantenerumab) results in house #CTAD22 $BIIB $ESALY $LLY", "author_id": "67066114"}
